PET scanning and measuring the impact of treatment.
Positron emission tomography (PET) scanning with F18-fluorodeoxyglucose or FDG is a becoming a standard method for tumor staging. The prediction and evaluation of therapy response are newer applications of FDG-PET. PET often offers an early readout of treatment efficacy and is an attractive alternat...
| Publicado en: | Cancer Journal Vol. 8; no. 2; pp. 119 - 120 |
|---|---|
| Autores principales: | , , , |
| Formato: | review Journal Article |
| Publicado: |
Lippincott Williams & Wilkins
Mar/Apr2002
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=106096740&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 106096740 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 15289117 4U5 jtl: Cancer Journal issn: 15289117 maglogo: N pubinfo: dt: Mar/Apr2002 vid: 8 iid: 2 pid: 5086 pub: Lippincott Williams & Wilkins place: Baltimore, Maryland artinfo: ui: 106096740 NLM11999946 2009446895 10.1097/00130404-200203000-00006 NLM11999946 106096740 ppf: 119 ppct: 1 formats: fmt: – @attributes: type: T – @attributes: type: P tig: atl: PET scanning and measuring the impact of treatment. aug: au: Cohade C Wahl RL Cohade, Christian Wahl, Richard L affil: Division of Nuclear Medicine, The Johns Hopkins Hospital, Baltimore, Maryland 21287-0817, USA sug: subj: Neoplasms Radiography Neoplasms Therapy Tomography, Emission-Computed Fludeoxyglucose F 18 Diagnostic Use Radiopharmaceuticals Diagnostic Use Treatment Outcomes ab: Positron emission tomography (PET) scanning with F18-fluorodeoxyglucose or FDG is a becoming a standard method for tumor staging. The prediction and evaluation of therapy response are newer applications of FDG-PET. PET often offers an early readout of treatment efficacy and is an attractive alternative to conventional anatomic assessments of treatment response. This article reviews the methods available with PET to monitor therapy response. Disease specific applications of PET imaging are then reviewed. While FDG is the most commonly used radiotracer for PET, many other radioligands could be applied in the future. pubtype: Academic Journal doctype: review Journal Article ougenre: Article language: English refInfo: holdings: @attributes: islocal: N |
|---|